NASDAQ:AMRS - Nasdaq - US03236M2008 - Common Stock - Currency: USD
0.05
-0.01 (-21.87%)
The current stock price of AMRS is 0.05 USD. In the past month the price decreased by -94.62%. In the past year, price decreased by -98.26%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
SHW | SHERWIN-WILLIAMS CO/THE | 30.41 | 86.78B | ||
ECL | ECOLAB INC | 39.74 | 74.95B | ||
DD | DUPONT DE NEMOURS INC | 20.06 | 34.13B | ||
PPG | PPG INDUSTRIES INC | 14.17 | 26.63B | ||
IFF | INTL FLAVORS & FRAGRANCES | 18.58 | 20.43B | ||
RPM | RPM INTERNATIONAL INC | 22.82 | 15.58B | ||
EMN | EASTMAN CHEMICAL CO | 12.51 | 11.44B | ||
SQM | QUIMICA Y MINERA CHIL-SP ADR | N/A | 11.33B | ||
ALB | ALBEMARLE CORP | N/A | 9.54B | ||
AXTA | AXALTA COATING SYSTEMS LTD | 16.08 | 7.86B | ||
ESI | ELEMENT SOLUTIONS INC | 18.4 | 6.42B | ||
ALTM | ARCADIUM LITHIUM PLC | 12.65 | 6.26B |
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 1,598 full-time employees. The company went IPO on 2010-09-28. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The firm leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
AMYRIS INC
5885 Hollis St Ste 100
Emeryville CALIFORNIA 94608 US
CEO: John G. Melo
Employees: 1598
Company Website: https://www.amyris.com/
Phone: 15104500761.0
The current stock price of AMRS is 0.05 USD. The price decreased by -21.87% in the last trading session.
The exchange symbol of AMYRIS INC is AMRS and it is listed on the Nasdaq exchange.
AMRS stock is listed on the Nasdaq exchange.
14 analysts have analysed AMRS and the average price target is 1.74 USD. This implies a price increase of 3384.94% is expected in the next year compared to the current price of 0.05. Check the AMYRIS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AMYRIS INC (AMRS) has a market capitalization of 18.47M USD. This makes AMRS a Nano Cap stock.
AMYRIS INC (AMRS) currently has 1598 employees.
The Revenue of AMYRIS INC (AMRS) is expected to grow by 76.61% in the next year. Check the estimates tab for more information on the AMRS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AMRS does not pay a dividend.
AMYRIS INC (AMRS) will report earnings on 2023-11-06, after the market close.
AMYRIS INC (AMRS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.67).
ChartMill assigns a fundamental rating of 1 / 10 to AMRS. Both the profitability and financial health of AMRS have multiple concerns.
Over the last trailing twelve months AMRS reported a non-GAAP Earnings per Share(EPS) of -1.67. The EPS decreased by -595.83% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 73% to AMRS. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 67.21% and a revenue growth 76.61% for AMRS